Cardiovascular Systems' GAAP loss for 6 months of fiscal year 2022 was $17.585 million, up 8.2 times from $2.132 million in the prior year. Revenue decreased 5.8% to $117.505 million from $124.713 million a year earlier.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept